Advertisement
Cleveland Clinic’s Center for Ileal Pouch Disorders (CIPD) was the first multidisciplinary facility of its kind in the world, and is currently the largest. CIPD gastroenterologists and colorectal surgeons see the nation’s highest volumes of both initial and reoperative J-pouch cases, with more than 5,000 initial and 500 reoperative pouch surgeries, including pouches that have failed either from disease or complications related to prior surgical procedures.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Ileal pouch surgery has revolutionized the care offered today. Ileal pouch patients have significantly improved quality of life; they do not need to carry a permanent stoma bag. The operative success rates at Cleveland Clinic are 96 percent in ulcerative colitis patients for initial pouches and 85 percent for redo pouches or pouch revision surgery. Yet the pouch procedure is technically challenging and can result in various mechanical and inflammatory conditions, including strictures, anastomotic leaks and pouchitis.
“Pouchitis used to be a mixed bag of everything together,” says Bo Shen, MD, one of the nation’s first gastroenterologists specializing in pouch disorders. “Now, we subclassify them based on etiology, disease mechanism, clinical presentation and disease course. If we have the correct classification, here’s the proper solution. It’s a much more analytical approach.”
The CIPD is home to the majority of the original pouchitis research done in the United States, including studies of:
For more information, please contact Dr. Shen at 216.444.9252 or shenb@ccf.org.
Advertisement
Advertisement
Experienced team approach leads to better outcomes
New hope for treating cancers in the peritoneal cavity
POEM, ESD among new group’s minimally invasive offerings
Findings could help identify patients at risk for poor outcomes
Findings also indicate reduced risk of serious liver events
Promising results could lead to improved screening, better outcomes
Significant improvement in GCSI scores following treatment